New low of 31 cases in a day, region again reports zero deaths

New low of 31 cases in a day, region again reports zero deaths

FacebookTwitterLinkedinEMail
AA
Text Size
  • Small
  • Medium
  • Large
Nagpur: From 37 Covid-19 cases reported in Vidarbha on Sunday, the number further declined to 31 on Monday. Also, no Covid-19 death was reported in the region, which has happened for the fourth time in the last seven days.
But the number of tests reduced to 8,295 – lowest-ever in the second wave so far — probably due to Sunday. Yet, the test positivity rate remained under 0.4%, which is the biggest positive indicator for the day.
Three districts – Bhandara, Wardha and Gondia — reported zero new cases while Chandrapur and Yavatmal reported one case each. This means half of Nagpur division had no cases on Monday.
Highest nine cases were reported in Amravati. This means, all districts reported new cases in single digit on Monday.
On the other hand, 59 patients, near double of new cases, recovered in a day. Now, out of 11,14,616 patients reported so far, 10,92,634 have recovered, which means the recovery rate is comfortably above 98%. This is better than average recovery rate for both state and country.
Only 659 patients are now under treatment in the region. Barring Nagpur (224), and Amravati (105), all other districts have active cases in double digit only.
Bhandara and Yavatmal have seven patients each under treatment, which is the lowest in the state. With active cases under 700, most oxygen beds in Vidarbha are now unoccupied. Still, entire region is under level 3 restrictions at least by August 1 as per the latest orders.
Chandrapur: There were zero casualties and lone detection on Monday. The day witnessed 13 recoveries and active patients dropped below 100, first time since onset of second wave, to reach 91 under treatment. Total caseload is at 84,979, out of which 83,354 have recovered and 1,534 have succumbed to the deadly virus.
Amravati: Nine new cases and seven recoveries took the district's caseload to 96,479 and total recoveries to 94,813 on Monday. There was no Covid death on the eighth successive day today. This ensured constancy of the toll at 1,561. Now there are 105 active cases under treatment.
Yavatmal: The district has no death report on Monday for the 37th consecutive day which keeps the death toll unchanged at 1,789. The administration has received 216 test reports, of which only one person was found positive. Currently there are 7 active positive patients undergoing treatment in hospitals. Of the 72,791 positive patients, 70,997 have recovered. There was no recovery on Monday. The test positivity rate is 10.45% and death rate is 2.45%. The daily positivity rate is 0.46%.
Wardha: Six patients were discharged, decreasing the active positive to 24 in district, while no positive, no death was reported on Monday. The total cases stand at 49,360 and toll at 1,324. The total recoveries increased to 48,012.
Akola: Of the 506 tests conducted in the last 24 hours, only two came positive. No recovery was reported. The caseload is 57,750, including 56,556 recoveries. The cumulative toll is 1,133. Now, 61 patients are under treatment.
Washim: There were four new cases and 8 recoveries on Monday. The district now has 41,645 cases, 40,973 recoveries and 622 deaths till date while 49 patients are under treatment.
Buldhana: There were three cases from 1,109 tests done in the last 24 hours. Now, the caseload is 87,240. Four patients recovered in a day taking the total to 86,552. Now, 16 patients are under treatment.
Gondia: Gondia did not register any new case, death and recovery on Monday, leaving 11 patients under treatment. The district conducted 176 tests in the last 24 hours.
Bhandara: The district conduct 92 tests to return with zero cases. There were no recoveries and deaths too. There are seven patients under treatment.
Gadchiroli: Five out of 219 tests done in the last 24 hours came positive, taking the caseload to 30,563. With 12 recoveries on Monday, the count reached 29,756. Now, 64 patients are under treatment.
FacebookTwitterLinkedinEMail
Start a Conversation
end of article